So first the “less good” news … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: OPKO, point of care, PSA, Sangia, test | 6 Comments »
-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
-
PCaI’s ASVSG
If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.
CureTalks on PCa
Our most recent CureTalk on Prostate Cancer (on February 21 this year) features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.
For access to the full list of CureTalks on Prostate Cancer, please click here.
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- Important upcoming conferences and educational events
- The continuing importance of the digital rectal exam
- Geographic risk for advanced and metastatic prostate cancer
- Early data from the LuPIN trial in men with mCRPC
- ADT is associated with risk for Alzheimer’s and dementia in largest study to date
- Patient-reported outcomes and the management of prostate cancer
- Evidence for dose escalation in adjuvant/salvage radiation
- The role of nutrition in management of prostate cancer patients on ADT
- New urine test shows promising results in detecting, classifying risk for prostate cancer
- Mutations to FOXA1 may be key to some aggressive forms of prostate cancer
- Genomic data and prostate cancer risk classification: an update
- Decision aids and prostate cancer: how useful are they?
- Strategies to maintain sexual function post-treatment for prostate cancer
- 3-year outcomes of men on AS in US community urology settings
- Patient satisfaction and the management of localized prostate cancer
… and Archives
Blog at WordPress.com. WP Designer.
